Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.
Pooled HELIOS-A/HELIOS-B safety included 707 patients (30.3% hereditary; remainder wild-type) with median 33.4 months of therapy and exposure up to 58 months. Exposure-adjusted overall and serious ...
Kevin M. Alexander, MD, eagerly awaits the presentation of new amyloid dataat the 2026 ACC meeting in New Orleans and is especially interested in the subgroup analyses from the ATTRibute-CM and HELIOS ...
Outpatient HF worsening occurred in 49.1% of patients and identified a large subgroup with higher event burden than hospitalization-based metrics alone captured. Experiencing outpatient HF worsening ...
American College of Cardiology (ACC), and nine other leading medical organizations have released updated guidelines for ...
The latest cholesterol guidelines include three new screening tests: coronary artery calcium, lipoprotein (a), and apolipoprotein B.